Any current/future new fundraising through debt or equity?

There is no mention of any current or future fundraising through debt or equity in the provided transcript of Galaxy Surfactants Limited's Q2 & H1 FY '25 earnings call. The discussion primarily focuses on business performance, market demand, supply chain challenges, pricing, and growth strategies. Management did not indicate plans for raising additional capital via debt or equity during the call. The focus appears to be on operational improvements and market expansion rather than external financing.

Future growth expectations in sales/revenue/volumes?

Galaxy Surfactants expects overall volume growth of 6% to 8% for FY 2025, aiming for the upper end of this range. India is likely to see a delayed growth of around 1% to 2% for the full year, with a demand slowdown continuing for the next two quarters but some recovery expected later. AMET (Africa, Middle East, Turkey) market is expected to show visible growth in H2 FY 2025, with full-year growth around 4% to 5%, recovering from supply chain disruptions. Rest of the World (ROW) has already seen high volume growth (~26% in H1) with a moderation expected in H2, targeting mid-teens volume g

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects volume growth of 6% to 8% for FY 2025, targeting the upper end of this range. EBITDA per metric tonne guidance is maintained at Rs. 20,500 to Rs. 21,500, with anticipated improvement in H2 driven by premium specialty products. Premium specialty segment, especially in Europe and North America, is expected to gain traction in H2 FY 2025 as inflation eases and interest rates reduce. India market expected to show modest volume growth of 1%-2% for the full year, with AMET region projected to grow 4%-5%, including recovery in H2. Rest of the world (ROW) region has delivered stron

Galaxy Surfactants LtdQ2 FY25Chemicals & Petrochemicals

Galaxy Surfactants Ltd Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹2,502P/E: 24.4Market Cap: ₹8.9K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Galaxy Surfactants expects overall volume growth of 6% to 8% for FY 2025, aiming for the upper end of this range.
India is likely to see a delayed growth of around 1% to 2% for the full year, with a demand slowdown continuing for the next two quarters but some recovery expected later.
AMET (Africa, Middle East, Turkey) market is expected to show visible growth in H2 FY 2025, with full-year growth around 4% to 5%, recovering from supply chain disruptions.
Rest of the World (ROW) has already seen high volume growth (~26% in H1) with a moderation expected in H2, targeting mid-teens volume growth for the full year.
Growth in premium specialty products and new product development is expected to aid EBITDA per metric tonne and value growth.
Demand revival is anticipated gradually across regions but not simultaneously, dependent on inflation and spending trends.
The company anticipates continued focus on new markets, specialty segments, and tier 2/3/local customers.

Margin guidance

Category 3

The company expects volume growth of 6% to 8% for FY 2025, targeting the upper end of this range.
EBITDA per metric tonne guidance is maintained at Rs. 20,500 to Rs. 21,500, with anticipated improvement in H2 driven by premium specialty products.
Premium specialty segment, especially in Europe and North America, is expected to gain traction in H2 FY 2025 as inflation eases and interest rates reduce.
India market expected to show modest volume growth of 1%-2% for the full year, with AMET region projected to grow 4%-5%, including recovery in H2.
Rest of the world (ROW) region has delivered strong growth (~26% in H1), expected to moderate but sustain mid-teens volume growth for the full year.
EBITDA per kg expected to improve in H2 due to better traction in premium specialty care products and operational efficiencies.
The management remains optimistic about ending FY 2025 on a positive note despite external challenges.

See what Galaxy Surfactants Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no mention of any current or future fundraising through debt or equity in the provided transcript of Galaxy Surfactants Limited's Q2 & H1 FY '25 earnings call.
The discussion primarily focuses on business performance, market demand, supply chain challenges, pricing, and growth strategies.
Management did not indicate plans for raising additional capital via debt or equity during the call.
The focus appears to be on operational improvements and market expansion rather than external financing.

Order book

The transcript provided does not explicitly mention details about Galaxy Surfactants Limited's current or expected orderbook or pending orders. However, some relevant insights related to order fulfillment and supply challenges include: - Supply-side challenges, including sudden rise in fatty alcohol prices and unavailability of containers, have disturbed momentum in the quarter. - The supply chain faced elongated disruptions due to geopolitical issues, notably the Red Sea blockade impacting AMET region shipments. - Supply chain situation has improved compared to FY 2022 or 2023 but inflationary effects continue. - There is mention of filling more orders despite supply chain delays, especially in AMET markets. - Freight rates have seen some correction but remain high; management is confident in managing freight and passing on costs to customers. - The company emphasizes strong engagement with customers to support inventory management and demand forecasting. No specific quantitative data on the orderbook or pending orders is disclosed in the transcript.

See what Galaxy Surfactants Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

The transcript does not provide specific details on current or future capital expenditure or strategic investments. However, it mentions the following related points: - Establishment of subsidiaries (not just offices) in Europe and Mexico to enhance go-to-market strategy and compete better in these regions by reducing freight costs and strengthening local presence. - Setting up subsidiaries aims to underline the strategic importance of these geographies and capture larger projects, reflecting a strategic investment in global expansion. - No explicit mention of capital expenditure amounts or timelines. - Focus appears on business development of specialty ingredients and premium products, indicating possible ongoing investment in innovation and specialty segment capabilities. Overall, the company is prioritizing strategic investments in geographical expansion and specialty products but has not disclosed detailed capex figures or timelines.

Track Galaxy Surfactants Ltd — get its next earnings analysis in your feed

How does Galaxy Surfactants Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisGalaxy Surfactants Ltd

Rev 3Mar 3

See where Galaxy Surfactants Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Galaxy Surfactants Ltd rank in Chemicals & Petrochemicals?

Compare Galaxy Surfactants Ltd against every Chemicals & Petrochemicals company (Q2 FY25) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Galaxy Surfactants Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Paushak Ltd (Q2 FY27)
Year-on-year increase in quarterly revenue: Rs 3,054 lakhs (approximately 52% growth) . Key results statement takeaways from Paushak Ltd's Q2 FY27 results state
Platinum Industries Ltd (Q2 FY26)
Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri
Neogen Chemicals Ltd (Q2 FY26)
Neogen Chemicals rebuilding plant with potential incremental capex post insurance evaluation, mostly double-digit crores, no large capex planned next 1-2…
Vishnu Chemicals Ltd (Q2 FY26)
Q2FY26 operating revenues: ₹401.1 Cr, a 16.7% year-on-year (YoY) increase from ₹343.8 Cr in Q2FY25. Key investor presentation takeaways from Vishnu Chemicals Lt

Compare:vs Solar Industries vs SRF Ltd vs Linde India Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Galaxy Surfactants Ltd Q2 FY25 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Galaxy Surfactants Ltd rank in Chemicals & Petrochemicals?

Continue your research

What Galaxy Surfactants Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season